Sydnexis Appoints Nick Ruth Chief as Commercial Officer

Sydnexis has announced the appointment of industry veteran Nick Ruth, MBA, as its Chief Commercial Officer (COO). Mr. Ruth will lead Sydnexis’ commercial strategy and transition from a clinical based organization to both a clinical and commercial based organization.

With 25 years of industry experience, Mr. Ruth has a strong and diverse track record of commercial success in both the ophthalmic pharmaceutical and surgical industries, Sydnexis stated in a news release. Prior to joining Sydnexis, Mr. Ruth held roles at Carl Zeiss Meditec, Alcon, and Novartis. 

“We are thrilled to welcome Nick to Sydnexis as our new Chief Commercial Officer. With his background in creating and building teams and spearheading numerous product launches, we are looking forward to Nick playing a vital role in the continued growth of our company,” said Patrick Johnson, President of Sydnexis.

“It is a privilege and I am honored to join Sydnexis to further its mission to treat progressive myopia in children and minimize the risk of associated sight threatening conditions later in life,” said Mr. Ruth. “Success in achieving this mission does not happen organically. It is the result of having a great team of people who are passionate and selfless in achieving this mission. I am looking forward to collaborating with the talented team at Sydnexis to help fight this significant and growing unmet need.”